Skip to content
Recall Observatory FDA recall evidence

Drug product

Idarubicin Hydrochloride Injection 20 mg/20 mL, 20 mL single-dose vial, Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0703-4156-11

D-0734-2021

July 29, 2021

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 88442
Status
Terminated
Classification
Class II
Quantity
2,091 vials
Official record key
drug-enforcement:D-0734-2021

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot #: 31328668B, exp. date 04/2023

Distribution pattern: Product was distributed Nationwide, including Puerto Rico.

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility